{
    "elements": [
        {
            "type": "table",
            "sequence_num": 1,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "RESEARCH & DEVELOPMENT Trial Master File"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MEHTSOP062"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "SOP"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th12 December 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "th11 December 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Service Development"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "17"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Research & Development"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Lauren Perkins, R & D Manager"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Research and Development"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "04/07/2019"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Tracey Camburn R & D Director, Clinical Lead Nurse"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "26/07/2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "DRAG Chair's Action"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "12th December 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: December 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 2,
            "data": {
                "url": "MEHTSOP062 TMF 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Stacey Cotterell"
                    },
                    {
                        "text": "Clinical Research Co-ordinator"
                    },
                    {
                        "text": "04/07/2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "MEHTSOP003 SOP on SOPs MEHTSOP004 SAEs (Sponsored) MEHTSOP005 Informed Consent MEHTSOP006 SAEs (Hosted) MEHTSOP061 Research Staff Training MEHTSOP050 Archiving of Essential Documents"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 10,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Lauren Perkins"
                    },
                    {
                        "text": "Newly created"
                    },
                    {
                        "text": "12th December 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 6,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Applicable"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Procedure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "text": "Appendix 1.0 - Definitions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "text": "Appendix 2.0 - Sample Trial Master File Contents Appendix 3.0 - Masterfile Checklist"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "Appendix 4.0 - Guidance Note on Site File Documentation Appendix 5.0 - File Note Template"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "text": "Appendix 6.0 \u2013 Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "BACKGROUND"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This document sets out the procedures to be followed by all Mid Essex Hospital Services NHS Trust (MEHT) staff who are involved in the preparation, maintenance and archiving of Trial Master Files (TMFs) and/or Site Files for research projects managed, sponsored or hosted by MEHT."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "It provides guidance on how the Sponsor File should be compiled and how these files should be stored to ensure compliance with the Trust's policies"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "PURPOSE"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "text": "\u25cf To achieve standard best practice of clinical research documentation for clinical trials sponsored by MEHT"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "text": "\u25cf To ensure MEHT meets all regulatory, research governance and Trust requirements in the management of TMFs and other related documentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "text": "\u25cf To ensure all clinical trials documentation can be readily available for regulatory and/or other auditing activities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "text": "\u25cf To ensure new research staff are appropriately trained in the setup and management of the TMF"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "APPLICABLE TO"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Any relevant Trust employee (including those with an honorary research contract or letter of access) involved with Clinical Trials of an Investigational Medicinal Product (CTIMP) sponsored by MEHT including, but not limited to, Chief Investigators (CI), Principal Investigators (PI), Co-investigators, Consultants, Research Fellows, Clinical Trial Pharmacists, Research Managers, Statisticians, Research Nurses, Research Midwives, Trial Coordinators & Data Managers."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "RESPONSIBILITIES"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "The Medicines for Human Use (Clinical Trials) Regulations 2004:1031 (as amended) outlines requirements for Trial Master File and archiving, as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor will keep a TMF for a clinical trial. Where MEHT is the Sponsor of the study, this is generally delegated to the CI or delegated individual (DI)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Where this is the case and MEHT is also a participating centre in the study, the Site Investigator site File (ISF) would be the same as the Trial Master File (TMF)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Where responsibility for the trial is delegated to a trials unit or external organisation, particularly in the case of co-sponsorship arrangements, the TMF would not be expected to include the SIF"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor will ensure that the TMF is readily available at all reasonable times for inspection by the licensing authority or any person appointed by the Sponsor to audit the arrangements for the trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The CI/DI will ensure access to the TMF and related documents are available upon request of the R&D Office to conduct routine Sponsor audits"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The CI/DI should ensure that the TMF contains the essential documents relating to that clinical trial, which enable both the conduct of the clinical trial and the quality of the data produced to be evaluated. It must also contain evidence of trial conduct in accordance with the applicable requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor should ensure that the essential documents contain information specific to each phase of the trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor should ensure that any alteration to a document contained, or which has been contained, in the TMF should be traceable. The Sponsor and the CI should ensure that the documents contained, or which have been contained, in the TMF are retained for at least 5 years after the conclusion of the trial and that during that period are:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "(a) Readily available to the licensing authority on request and (b); complete and legible"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor and CI should ensure that the medical files of trial subjects are retained for at least 5 years after the conclusion of the trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "\u25cf The Sponsor should appoint named individuals within the organisation to be responsible for archiving the documents which are, or have been, contained in the TMF and access to those documents should be restricted to those appointed individuals"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "\u25cf If there is transfer of ownership of data or documents connected with the clinical trial\u2014"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "o the Sponsor should record the transfer; and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "o The new owner should be responsible for data retention and archiving"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "PROCEDURE"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "All clinical trials sponsored by MEHT must have a comprehensive and up-to-date TMF. Appendix  provides a sample template for the TMF contents. The International Conference on Harmonisation- Good Clinical Practice (ICH-GCP) Master File checklist is also provided as guidance in Appendix  For further guidance on Site File documentation see Appendix"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "The TMF will be verified at the study initiation meeting. This should be used to maintain a current TMF by the Research Team. If units have existing systems for managing the contents of the TMF (e.g. local guidance documents), then the existing system can be used provided it is GCP-compliant."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Copies of all versions of the protocol should be stored in the TMF. If older versions of protocols are stored elsewhere, a file note must be added to the TMF. All protocols should be approved by the CI prior to implementation; an authorisation signature and date by the CI should be included in the protocol."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "The TMF should contain copies of sample Patient Information Sheet (PIS), Consent Forms, GP letters and blank Case Report Forms (CRFs)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "All completed CRFs should be maintained in the TMF and/or Site File or in a secure location within the designated location and a file note must be added in the TMF describing the location and other relevant information (e.g. contact)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "All documentation arising from communication between the study team and the R&D Office should be maintained in the appropriate section of the TMF. Prior to study initiation, the CI/DI should ensure a final approval has been granted. This also applies to all substantial and non-substantial amendments."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "All documentation relating to the study and the ethics committee should be maintained in the TMF. The CI must ensure all Health Research Authority (HRA) approvals are obtained prior to study start. This also applies to all substantial amendments."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "All communication documentation relating to the study and the Medicines and Healthcare products Regulatory Agency (MHRA) should be maintained in the TMF, where applicable. The CI must ensure all necessary regulatory approvals are in place prior to study start. For studies involving an Investigational Medicinal Product (IMP), the CI should ensure that an MHRA Clinical Trial Authorisation (CTA) is obtained prior to study start."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "All documentation relating to research governance arrangements should be maintained in the TMF. Examples of documents include sponsorship letters, Clinical Trials Advisory & Awards Committee (CTAAC), Administration of Radioactive Substances Advisory Committee (ARSAC), Research Agreements and Indemnity Statement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "For trials involving unlicensed IMPs an Investigator's Brochure (IB) should be maintained in the TMF. The CI should ensure that updated IBs are in circulation. For marketed products, an approved version of the Summary of Product Characteristics (SPC) should be maintained in the TMF. If IBs/ SPCs are not held within the TMF, a File Note should be included in the TMF describing the location."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 5.11,
                "text": "All documentation relating to pharmacy and the trial should be maintained in the TMF. If documents are held in Pharmacy Study File instead of the TMF, a file note should be added to the TMF. See Appendix 5 for sample file note."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 5.12,
                "text": "All laboratory documentation related to the study should be maintained either within the TMF or held centrally within the units or designated centres. If held centrally, a file note must be added to the TMF. Examples of documentations include accreditations, normal reference ranges, investigational product handling, invoices etc."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 1,
                "prefix": 5.13,
                "text": "The TMF should contain study site staff records including items such as responsibilities and signature log (delegation log), evidence of GCP training, SOP training, current CVs (recommended to be updated every 2-3 years). If training records are held centrally within units, a file note can be added in the TMF."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 5.14,
                "text": "Study specific information, guidance notes and randomisation instructions should be maintained in the appropriate section(s) of the TMF."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 5.15,
                "text": "All information regarding pharmacovigilance should be maintained in the TMF. Records of Adverse Events (AEs) and Serious Adverse Events (SAEs), including follow-up reports should be maintained in the TMF. Other items including safety information, sample SAE forms, SAE logs, correspondences, Safety Reports to the MHRA, HRA and annual progress reports should also be held in the TMF."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 5.16,
                "text": "If documents are held elsewhere, a file note should be added to the TMF (Appendix"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "5). If, as part of the sponsor agreement, pharmacovigilance was delegated to a co- sponsor that is not MEHT then this section does not apply."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 5.17,
                "text": "All substantial and non-substantial amendments must be submitted to the RDAG for review and approval. All correspondences, including copies of approvals for substantial amendments from the HRA and MHRA should be held in the TMF."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "prefix": 5.18,
                "text": "All evidence of monitoring activities such as study initiation meetings, progress reports, minutes of research/team meetings, meetings of Data Monitoring Committees and Trial Steering Groups and monitoring logs should be held in the TMF."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "prefix": 5.19,
                "text": "For trials that have been audited by a monitor/auditor, it is recommended that audit reports are held separately from the TMF. Copies of all audits are maintained by the R&D Office."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "The TMF should contain evidence/rationale for the selection of external vendors including a copy of the vendor oversight programme."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 5.21,
                "text": "Other miscellaneous documentations such as publications, end-of-trial notifications, archiving etc. should also be maintained in the TMF as appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 5.22,
                "text": "The TMF should be archived following study conclusion in accordance with Trust, Sponsor and regulatory requirements (see gSOP-17)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 5.23,
                "text": "Where MEHT is sponsoring a multicentre trial, the MEHT coordinating trial team should ensure that a site-specific TMF (site level) is set up and maintained during the course of the study (see appendix 2,3 and 4)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "REFERENCES"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "The Medicines for Human Use (Clinical Trials) (2004) regulations ICH GCP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "EQUALITY IMPACT ASSESSMENT"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 6)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Definitions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 1,
                "text": "Adverse Event (AE) - Any untoward medical occurrence in a patient or clinical trial subject administered a medicinal product and which does not necessarily have a causal relationship with this treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 1,
                "text": "Case Report Form (CRF) - A printed, optical, or electronic document designed to record all of the protocol required information to be reported to the Sponsor on each trial subject."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "text": "Chief Investigator (CI) - The person who takes overall responsibility for the design, conduct and reporting of a study if it is at one site; or if the study involves researchers at more than one site, the person who takes primary responsibility for the design, conduct and reporting of the study whether or not that person is an Investigator at any particular site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 1,
                "text": "Clinical Trial - Any investigation in human subjects, other than a non-interventional trial intended to discover or verify the clinical, pharmacological or other pharmacodynamic effects of one or more medicinal product or to identify any adverse reactions to one or more such products and to study absorption, distribution metabolism and excretion in one of more such products with the object of ascertaining the safety or efficacy of those products."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "text": "Clinical Trial Authorisation (CTA) - Regulatory approval issued by a competent authority to conduct a clinical trial within an EU Member State."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 1,
                "text": "Clinical Trial of an Investigational Medicinal Product (CTIMP) - This is defined as any Clinical Research Study which intends to generate new information about the safety or efficacy of a Medicinal Product."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "text": "Good Clinical Practice (GCP) - The principles of Good Clinical Practice in Clinical Trials as set down in Articles 2-5 of the GCP Directive and implemented in the UK by Schedule 1 of the Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I.2004/1031) as amended by S.I. 2006/1928."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "Good Clinical Practice is a set of internationally recognised ethical and scientific quality requirements which must be observed for designing, conducting, recording and reporting clinical trials that involve the participation of human subjects."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 1,
                "text": "Honorary Research Contract (HRC) -  HRCs are required for researchers who are not employees of the NHS and whose activities could have a foreseeable and direct impact on patient care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "text": "Investigational Medicinal Products (IMP) - A pharmaceutical form of an active substance or placebo being tested, or used as a reference in a clinical trial. This includes a medicinal product which has a marketing authorisation but is, for the purposes of the trial -"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "\u25cf used or assembled (formulated or packaged) in a way different from the form of the product authorised under the authorisation,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "\u25cf used for an indication not included in the summary of product characteristics under the authorisation for that product, or"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "\u25cf used to gain further information about the form of that product as authorised under the authorisation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 1,
                "text": "Pharmacovigilance - The regulations outline procedures for the recording and reporting of safety events (Adverse Events or Suspected Unexpected Serious Adverse Reactions) arising from clinical trials."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "text": "Letter of Access - Letters of access enable NHS employees or staff with an honorary clinical contract (e.g. clinical academics) with one NHS organisation to conduct research in another NHS organisation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 1,
                "text": "Principal Investigator (PI) - The leader responsible for a team of individuals conducting a study at a (participating) site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "text": "Serious Adverse Event (SAE) or Serious Adverse Reaction (SAR) -  Any untoward medical occurrence or effect that at any dose results in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Death"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Is life-threatening*"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Requires hospitalisation or prolongation of existing hospitalisation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Results in persistent or significant disability or incapacity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Is a congenital anomaly or birth defect"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "\u00b7 Is an important medical event"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "* \u201clife-threatening\u201d refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 1,
                "text": "Site File -  Site Files are held by the PI at sites and contain copies of the essential documents, local approvals, signed consent forms and completed data forms."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 1,
                "text": "Suspected Unexpected Serious Adverse Reaction (SUSAR) -  All suspected adverse reactions related to an Investigational Medicinal Product (IMP) that is both unexpected and serious."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 1,
                "text": "The Medicines & Healthcare products Regulatory Agency (MHRA) - The government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "The MHRA can also be defined as:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "MHRA (Medicines) is the competent authority for the UK in relation to the EU Directive and the Clinical Trials Regulations. MHRA (Devices) is the competent authority for the UK in relation to the Medical Devices Regulations 2002."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 1,
                "prefix": 2004.0,
                "text": "The Regulations - Medicines for Human Use (Clinical Trial) Regulations 2004 transposed the EU Clinical Trials Directive into UK legislation, as Statutory Instrument 2004 no  This became effective on the 1st May  An amendment to implement Directive 2005/28/EC was made to the Regulations as Statutory Instrument 2006 no 1928."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 1,
                "text": "Trial Master File - The Trial Master File (TMF) will be held at the principal site by the Sponsor, Chief Investigator or at the co-ordinating centre. The TMF should contain all essential documents defined as documents which individually and collectively permit evaluation of the conduct of a trial and the quality of the data produced. A TMF should be set up at the beginning of a trial and maintained up-to-date throughout the trial until trial conclusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "For trials currently running, it is recommended that Section 8 of the ICH-GCP Guideline is followed as guidance in order to meet statutory requirements. However, some of the documents listed may not be available or applicable in many non-commercial trials. The appropriate documentation will vary according to the trial and sponsor requirements."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Sample Trial Master File Contents"
            }
        },
        {
            "type": "table",
            "sequence_num": 107,
            "data": {
                "num_rows": 21,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Essential documents required for Trial Master File"
                    },
                    {
                        "text": "1"
                    },
                    {
                        "text": "Trial Summary"
                    },
                    {
                        "text": "2"
                    },
                    {
                        "text": "Version control log"
                    },
                    {
                        "text": "3"
                    },
                    {
                        "text": "Contact details sheet"
                    },
                    {
                        "text": "Trial Specific Documentation"
                    },
                    {
                        "text": "6"
                    },
                    {
                        "text": "Current approved protocol with signatures"
                    },
                    {
                        "text": "7"
                    },
                    {
                        "text": "Approved Patient Information Sheet (PIS), Informed Consent Form, GP Letter"
                    },
                    {
                        "text": "8"
                    },
                    {
                        "text": "Previous versions of protocol(s), PIS, Informed Consent Form, GP Letter"
                    },
                    {
                        "text": "9"
                    },
                    {
                        "text": "Study specific Standard Operating Procedures"
                    },
                    {
                        "text": "Sponsorship and NHS Permission"
                    },
                    {
                        "text": "10"
                    },
                    {
                        "text": "Trust Approval Letter"
                    },
                    {
                        "text": "11"
                    },
                    {
                        "text": "Letter of acceptance of sponsorship"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Peer Review"
                    },
                    {
                        "text": "13"
                    },
                    {
                        "text": "Sponsorship delegation log"
                    },
                    {
                        "text": "14"
                    },
                    {
                        "text": "Project Management Delegation Log"
                    },
                    {
                        "text": "15"
                    },
                    {
                        "text": "Risk Assessment and superseded versions"
                    },
                    {
                        "text": "Site Personnel"
                    },
                    {
                        "text": "16"
                    },
                    {
                        "text": "Up-to-date, signed and dated CVs and GCP training records"
                    },
                    {
                        "text": "17"
                    },
                    {
                        "text": "Delegation Log"
                    },
                    {
                        "text": "Finance"
                    },
                    {
                        "text": "18"
                    },
                    {
                        "text": "Grant Application"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Clinical Trial Agreement / Funding agreement letters  Finance correspondence: funder / contracts"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Indemnity certificates / policy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Site Agreements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Research Account statements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Invoices"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Finance correspondence with sites"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Other finance correspondence other than contracts"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "text": "MHRA and Ethics"
            }
        },
        {
            "type": "table",
            "sequence_num": 116,
            "data": {
                "num_rows": 9,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "27"
                    },
                    {
                        "text": "EUDRACT number"
                    },
                    {
                        "text": "28"
                    },
                    {
                        "text": "HRA correspondence"
                    },
                    {
                        "text": "29"
                    },
                    {
                        "text": "Adoption onto the NIHR portfolio"
                    },
                    {
                        "text": "30"
                    },
                    {
                        "text": "Ethics application including correspondence"
                    },
                    {
                        "text": "31"
                    },
                    {
                        "text": "Favourable Ethical Approval letter"
                    },
                    {
                        "text": "32"
                    },
                    {
                        "text": "MHRA application including correspondence"
                    },
                    {
                        "text": "33"
                    },
                    {
                        "text": "Clinical Trial Authorisation letter"
                    },
                    {
                        "text": "34"
                    },
                    {
                        "text": "Copy of the Annual Progress Report(s) to Ethics"
                    },
                    {
                        "text": "35"
                    },
                    {
                        "text": "Copy of the end of trial notification form and report sent to Ethics & MHRA"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 1,
                "text": "Amendments"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 1,
                "prefix": 36.0,
                "text": "Amendments to ethical approval, a separate bundle of documents filed in chronological"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "order for each amendment comprising copies of:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "1) all the amended documentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "2) approval \u2013 Ethics, MHRA, HRA, R&D (as required)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 1,
                "prefix": 37.0,
                "text": "Correspondence regarding the amendment Pharmacovigilance"
            }
        },
        {
            "type": "table",
            "sequence_num": 123,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "38"
                    },
                    {
                        "text": "Investigator's Brochure (IB) and/or Summary of Product Characteristics (SmPC) and updates"
                    },
                    {
                        "text": "39"
                    },
                    {
                        "text": "Pharmacovigilance SOP inc blank SAE forms"
                    },
                    {
                        "text": "40"
                    },
                    {
                        "text": "SAE reports"
                    },
                    {
                        "text": "41"
                    },
                    {
                        "text": "SUSAR reports"
                    },
                    {
                        "text": "42"
                    },
                    {
                        "text": "DSUR reports"
                    },
                    {
                        "text": "43"
                    },
                    {
                        "text": "Procedure for randomisation, unblinding and code break (if applicable)"
                    },
                    {
                        "text": "44"
                    },
                    {
                        "text": "Details of testing"
                    },
                    {
                        "text": "45"
                    },
                    {
                        "text": "Details of any code breaks"
                    },
                    {
                        "text": "46"
                    },
                    {
                        "text": "Details of any Protocol non-compliance or Serious Breach of protocol"
                    },
                    {
                        "text": "47"
                    },
                    {
                        "text": "Details of any Urgent Safety Measures"
                    },
                    {
                        "text": "48"
                    },
                    {
                        "text": "Notification of sponsors to Investigators of safety information"
                    },
                    {
                        "text": "49"
                    },
                    {
                        "text": "Copies of any adverse event reports made under the normal reporting procedures used by the Trust"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "text": "Pharmacy"
            }
        },
        {
            "type": "table",
            "sequence_num": 125,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "50"
                    },
                    {
                        "text": "Quality Agreement"
                    },
                    {
                        "text": "51"
                    },
                    {
                        "text": "Instructions for handling IMP (if not included in protocol)"
                    },
                    {
                        "text": "52"
                    },
                    {
                        "text": "Sample of label/ superseded versions of label (if applicable)"
                    },
                    {
                        "text": "53"
                    },
                    {
                        "text": "Shipping records, inc. ordering forms (if applicable)"
                    },
                    {
                        "text": "54"
                    },
                    {
                        "text": "IMP accountability"
                    },
                    {
                        "text": "55"
                    },
                    {
                        "text": "Termination: Documentation of IMP destruction"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "text": "Data Collection, Analysis and Publication"
            }
        },
        {
            "type": "table",
            "sequence_num": 127,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "56"
                    },
                    {
                        "text": "Data Management Plan"
                    },
                    {
                        "text": "57"
                    },
                    {
                        "text": "Database management"
                    },
                    {
                        "text": "58"
                    },
                    {
                        "text": "Sample case report forms (CRFs) + Copy of other approved data collection instruments (eg questionnaires)"
                    },
                    {
                        "text": "59"
                    },
                    {
                        "text": "Completed CRFs + data collection instruments"
                    },
                    {
                        "text": "60"
                    },
                    {
                        "text": "Data queries"
                    },
                    {
                        "text": "61"
                    },
                    {
                        "text": "Statistical Analysis Plan"
                    },
                    {
                        "text": "62"
                    },
                    {
                        "text": "Interim reports"
                    },
                    {
                        "text": "63"
                    },
                    {
                        "text": "Publication(s)"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 1,
                "text": "Monitoring"
            }
        },
        {
            "type": "table",
            "sequence_num": 129,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "64"
                    },
                    {
                        "text": "Monitoring Plan"
                    },
                    {
                        "text": "65"
                    },
                    {
                        "text": "Audit Plan"
                    },
                    {
                        "text": "66"
                    },
                    {
                        "text": "Trial initiation Report"
                    },
                    {
                        "text": "67"
                    },
                    {
                        "text": "Monitoring Reports"
                    },
                    {
                        "text": "68"
                    },
                    {
                        "text": "Audit Reports"
                    },
                    {
                        "text": "69"
                    },
                    {
                        "text": "Close Down Report"
                    },
                    {
                        "text": "70"
                    },
                    {
                        "text": "Correspondence regarding monitoring and/or audit"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 1,
                "text": "Meeting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "prefix": 71.0,
                "text": "Project team meetings"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 1,
                "prefix": 72.0,
                "text": "Project team correspondence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 1,
                "prefix": 74.0,
                "text": "Trial Steering Committee meeting Terms of Reference  Trial Steering Committee meeting minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 1,
                "prefix": 75.0,
                "text": "Trial Steering Committee correspondence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "prefix": 77.0,
                "text": "Data Monitoring Committee Charter / Terms of Reference  Data Monitoring Committee meeting"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 1,
                "prefix": 78.0,
                "text": "Data Monitoring Committee correspondence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "text": "Laboratory"
            }
        },
        {
            "type": "table",
            "sequence_num": 138,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "79"
                    },
                    {
                        "text": "Lab accreditation certificates"
                    },
                    {
                        "text": "80"
                    },
                    {
                        "text": "Normal values/ ranges"
                    },
                    {
                        "text": "81"
                    },
                    {
                        "text": "Record of retained tissue/ body samples (if any)"
                    },
                    {
                        "text": "82"
                    },
                    {
                        "text": "Material Transfer Agreements"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 1,
                "text": "Participant Logs and Consent Forms"
            }
        },
        {
            "type": "table",
            "sequence_num": 140,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "83"
                    },
                    {
                        "text": "Screening/enrolment log (including subject identification list)"
                    },
                    {
                        "text": "84"
                    },
                    {
                        "text": "Signed Consent Forms"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 1,
                "text": "Other"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 1,
                "prefix": 85.0,
                "text": "Copies of all other correspondence relating to the trial (excluding REC, MHRA and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "text": "R&D) records of all significant phone conversations relating to trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Masterfile Checklist"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "text": "Ref: Section 8, ICH Guidelines for Good Clinical Practice)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "Before the Clinical phase of the Trial Commences"
            }
        },
        {
            "type": "table",
            "sequence_num": 147,
            "data": {
                "num_rows": 13,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File)"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.2.1"
                    },
                    {
                        "text": "Investigator's Brochure"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (Front Page)"
                    },
                    {
                        "text": "8.2.2"
                    },
                    {
                        "text": "Signed protocol and amendments, if any, and sample Case Report Form (CRF)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (Protocol & Amendments)"
                    },
                    {
                        "text": "8.2.3"
                    },
                    {
                        "text": "Information given to trial subject Informed consent form"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "-Any other written documentation (for example GP Letter)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "-Advertisement for subject recruitment"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.2.4"
                    },
                    {
                        "text": "Financial aspects of the trial"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.2.5"
                    },
                    {
                        "text": "Insurance statement (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.2.6"
                    },
                    {
                        "text": "Signed agreement between involved parties, eg:"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "-investigator/ institution and authority(ies) where required"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.7"
                    },
                    {
                        "text": "Dated, documented approval of Independent Ethics Committee of the following: -protocol and any amendments -CRF (if applicable) - informed consent form(s) -any other written information to be provided to the subject(s) - advertisement for subject recruitment (if used) -subject compensation (if any) -any other documents given approval/ favourable opinion"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.2.8"
                    },
                    {
                        "text": "Independent Ethics Committee composition"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.9"
                    },
                    {
                        "text": "Regulatory Authority Authorisation (where required)"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X (where required)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 148,
            "data": {
                "num_rows": 2,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File)"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.2.10"
                    },
                    {
                        "text": "Curriculum vitae and other documents evidencing qualifications of investigator(s) and sub- investigator(s)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (CI/ PI only)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 149,
            "data": {
                "num_rows": 9,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "8.2.11"
                    },
                    {
                        "text": "Normal values/ranges for medical/laboratory/technical procedures and/or tests included in the protocol."
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.12"
                    },
                    {
                        "text": "Medical/laboratory/technical procedures/tests - certification or - accreditation or - established quality control and/or external quality assessment or -other validation (where required)"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.13"
                    },
                    {
                        "text": "Sample of label(s) attached to investigational medicinal product container(s)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.14"
                    },
                    {
                        "text": "Instructions for handling of investigational medicinal product(s) and trial-related materials (if not in protocol or Investigator Brochure)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.15"
                    },
                    {
                        "text": "Shipping records for investigational medicinal product(s) and trial related materials"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.16"
                    },
                    {
                        "text": "Certificate(s) of analysis of investigational product shipped"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.17"
                    },
                    {
                        "text": "Decoding procedures for blinded trials"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (third party if applicable)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.18"
                    },
                    {
                        "text": "Master Randomisation List"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X (third party if applicable"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.2.19"
                    },
                    {
                        "text": "Pre-trial monitoring report"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "During the clinical conduct of the trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "In addition to having on file the above documents, the following should be added to the files during the trial as evidence that all new relevant information is documented as it becomes available."
            }
        },
        {
            "type": "table",
            "sequence_num": 152,
            "data": {
                "num_rows": 8,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File)"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.3.1"
                    },
                    {
                        "text": "Investigator's Brochure updates"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (Front Page only)"
                    },
                    {
                        "text": "8.3.2"
                    },
                    {
                        "text": "Any revision to: -protocol/amendment(s) and CRF -informed consent form -any other written information provided to subjects (Patient Information Sheets)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (Protocol, Informed Consent, Patient Information Sheet))"
                    },
                    {
                        "text": "8.3.3"
                    },
                    {
                        "text": "Dated, documented approval of Independent Ethics Committee of the following: -protocol amendment(s) -revisions of: - informed consent form - any other written information to be provided to the subject (Patient Information Sheets) - any other documents given approval -continuing review of trial (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.3.4"
                    },
                    {
                        "text": "Regulatory Authority Authorisation where required for -protocol amendment(s) and other documents"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.3.5"
                    },
                    {
                        "text": "Curriculum vitae for new investigator(s) and sub- investigator(s)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (New CI/ PI only)"
                    },
                    {
                        "text": "8.3.6"
                    },
                    {
                        "text": "Updates to normal values/ranges for medical/laboratory/technical procedures and/or tests included in the protocol."
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.7"
                    },
                    {
                        "text": "Updates of medical/laboratory/technical procedures/tests --certification or - accreditation or - established quality control and/or external quality assessment or -other validation (where required)"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 153,
            "data": {
                "num_rows": 2,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File)"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.3.8"
                    },
                    {
                        "text": "Documentation of investigational medicinal product(s) and trial-related materials shipment"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 154,
            "data": {
                "num_rows": 18,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "8.3.9"
                    },
                    {
                        "text": "Certificates of analysis for new batches of investigational product"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.10"
                    },
                    {
                        "text": "Monitoring visit reports"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.3.11"
                    },
                    {
                        "text": "Relevant communication other than site visits -letters/ meeting notes/ notes of telephone calls/ printed emails"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.12"
                    },
                    {
                        "text": "Signed informed consent forms"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.13"
                    },
                    {
                        "text": "Source documents"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.14"
                    },
                    {
                        "text": "Signed, dated and completed case report forms (CRF)"
                    },
                    {
                        "text": "X (copy)"
                    },
                    {
                        "text": "X (original)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.15"
                    },
                    {
                        "text": "Documentation of CRF corrections"
                    },
                    {
                        "text": "X (copy)"
                    },
                    {
                        "text": "X (original)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.16"
                    },
                    {
                        "text": "Notification by originating investigator to sponsor of serious adverse events and related reports"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.17"
                    },
                    {
                        "text": "Notification by sponsor and/or investigator, where applicable, to Regulatory Authority and Independent Ethics Committee of unexpected serious adverse drug reactions and of other safety information"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.3.18"
                    },
                    {
                        "text": "Notification by sponsor to investigators of safety information"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.19"
                    },
                    {
                        "text": "Interim or annual reports to independent ethics committees and Authority"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.3.20"
                    },
                    {
                        "text": "Subject screening log"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X (where required)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.21"
                    },
                    {
                        "text": "Subject identification code list"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.3.22"
                    },
                    {
                        "text": "Subject enrolment log"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.23"
                    },
                    {
                        "text": "Investigational medicinal products accountability at site"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.24"
                    },
                    {
                        "text": "Signature sheet"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.3.25"
                    },
                    {
                        "text": "Record of retained body fluids/tissue samples (if any)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "After completion or termination of trial"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "After completion or termination of the trial, all of the documents identified in sections 8.2 and 8.3 should be in the file together with the following:"
            }
        },
        {
            "type": "table",
            "sequence_num": 157,
            "data": {
                "num_rows": 9,
                "num_cols": 5,
                "table_items": [
                    {
                        "text": "ICH GCP Ref."
                    },
                    {
                        "text": "Topic"
                    },
                    {
                        "text": "Located in Principal Investigator file (Site File)"
                    },
                    {
                        "text": "Located in Chief Investigator file (Trial Master File)"
                    },
                    {
                        "text": "Located in R&D Office file"
                    },
                    {
                        "text": "8.4.1"
                    },
                    {
                        "text": "Investigational medicinal product(s) accountability at site"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.2"
                    },
                    {
                        "text": "Documentation of investigational medicinal product destruction"
                    },
                    {
                        "text": "X (if destroyed at site)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.3"
                    },
                    {
                        "text": "Completed subject identification code list"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.4"
                    },
                    {
                        "text": "Audit certificate (if available)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.5"
                    },
                    {
                        "text": "Final trial close-out monitoring report"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "8.4.6"
                    },
                    {
                        "text": "Treatment allocation and decoding documentation"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.7"
                    },
                    {
                        "text": "Final report by investigator to Independent Ethics Committee where required"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "8.4.8"
                    },
                    {
                        "text": "Clinical study report"
                    },
                    {
                        "text": "X (if applicable)"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: Guidance Note on Site File Documentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "For MEHT sponsored multicentre studies, the following documents are also expected to be included."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Decoding procedures for blinded trials"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Copy of signed, dated and completed case report forms (CRF)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Documentation of CRF corrections (copy)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Notification by sponsor and/or investigator, where applicable, to Regulatory Authority and Independent Ethics Committee of unexpected serious adverse drug reactions and of other safety information (where required)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Interim or annual reports to independent ethics committees and Authority"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Subject screening log (original)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Subject identification code list (original)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Subject enrolment log (original)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Completed subject identification code list (original)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "text": "\u25cf Final report by investigator to Independent Ethics Committee (where required)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: File Note Template"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 1,
                "text": "File Note"
            }
        },
        {
            "type": "table",
            "sequence_num": 172,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Study:"
                    },
                    {
                        "text": "Principal Investigator:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Time:"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 1,
                "text": "Note:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 1,
                "text": "Print Name ......................................................................................................................................."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 1,
                "text": "Signature .......................................................................................Date........................................."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 1,
                "text": "Role \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.................................................."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "Research and Development Trial Master File/ MEHTSOP062/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 1,
                "text": "Appendix 6: Preliminary Equality Analysis"
            }
        },
        {
            "type": "image",
            "sequence_num": 180,
            "data": {
                "url": "MEHTSOP062 TMF 1.0.002.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Research and Development Trial Master File/ MEHTSOP062"
            }
        },
        {
            "type": "table",
            "sequence_num": 182,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "New SOP"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 184,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Lauren Perkins"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Research & Development Manager"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "July 2019"
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 185,
            "data": {
                "url": "MEHTSOP062 TMF 1.0.001.png"
            }
        }
    ]
}